SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000899140-15-000237
Filing Date
2015-02-13
Accepted
2015-02-13 17:16:17
Documents
2
Group Members
ORACLE ASSOCIATES, LLCORACLE INSTITUTIONAL PARTNERS, L.P.ORACLE PARTNERS, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G f13839798a.htm SC 13G 122220
2 JOINT FILING AGREEMENT f13839798b.htm EX-99.1 11696
  Complete submission text file 0000899140-15-000237.txt   135655
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
PLASMATECH BIOPHARMACEUTICALS INC (Subject) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-33655 | Film No.: 15616268
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ORACLE PARTNERS L P 200 GREENWICH AVENUE GREENWICH CT 06830
Business Address
FEINBERG LARRY N (Filed by) CIK: 0000926475 (see all company filings)

State of Incorp.: NY
Type: SC 13G